Klotho protein alleviates heart ischemia/reperfusion injury and oxidative stress through regulation of the NOS/MMP pathway

Guardado en:
Detalles Bibliográficos
Publicado en:Scientific Reports (Nature Publisher Group) vol. 15, no. 1 (2025), p. 32299-32316
Autor principal: Olejnik, Agnieszka
Otros Autores: Krzywonos-Zawadzka, Anna, Sambor, Izabela, Mysiak, Andrzej, Bil-Lula, Iwona
Publicado:
Nature Publishing Group
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3245813375
003 UK-CbPIL
022 |a 2045-2322 
024 7 |a 10.1038/s41598-025-18021-x  |2 doi 
035 |a 3245813375 
045 2 |b d20250101  |b d20251231 
084 |a 274855  |2 nlm 
100 1 |a Olejnik, Agnieszka  |u Division of Clinical Chemistry and Laboratory Haematology, Department of Medical Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A St., 50-556, Wrocław, Poland (ROR: https://ror.org/01qpw1b93) (GRID: grid.4495.c) (ISNI: 0000 0001 1090 049X) 
245 1 |a Klotho protein alleviates heart ischemia/reperfusion injury and oxidative stress through regulation of the NOS/MMP pathway 
260 |b Nature Publishing Group  |c 2025 
513 |a Journal Article 
520 3 |a Heart ischemia/reperfusion injury (IRI) significantly contributes to cardiac damage through oxidative and nitrosative stress, where the dysregulation of nitric oxide synthases (NOS) and the subsequent activation of matrix metalloproteinases (MMPs) are observed. Klotho is a multifunctional protein crucial in ageing, metabolism, and ion homeostasis. It has been confirmed that Klotho serves as a critical protective factor across multiple biological systems, with its roles in neuroprotection, cardiovascular health, and renal function being particularly noteworthy. This study aimed to investigate the protective role of Klotho protein against oxidative and nitrosative stress in heart IRI through regulation of the NOS/MMP pathway. The study utilised in vitro human cardiomyocyte culture and ex vivo isolated rat hearts subjected to IRI. Recombinant Klotho protein was administered to evaluate its effects on heart mechanical function, gene and protein expression of NOS isoforms, oxidative and nitrosative stress markers, MMP activity, and lipid metabolism. Administration of Klotho significantly improved heart mechanical and contractile function following ischemia/reperfusion. Klotho normalised the expression and synthesis of endothelial NOS and inducible NOS, resulting in reduced production of reactive nitrogen species and attenuated nitrosative stress. It also limited oxidative damage, reflected by decreased protein oxidation, and restored fatty acid metabolism. Additionally, Klotho regulated MMP-2 and MMP-9 synthesis and activity, thereby protecting heart contractile proteins from degradation. The Klotho protein exhibits significant cardioprotection in IRI by mitigating oxidative and nitrosative stress through the modulation of the NOS/MMP signalling pathway. These findings highlight the therapeutic potential of Klotho in managing ischemic heart conditions and myocardial injury. 
651 4 |a France 
651 4 |a United States--US 
651 4 |a Paris France 
653 |a Heart 
653 |a Neuroprotection 
653 |a Animals 
653 |a Heart failure 
653 |a Nitric oxide 
653 |a Ischemia 
653 |a Isoforms 
653 |a Laboratories 
653 |a Metabolism 
653 |a Reperfusion 
653 |a Kinases 
653 |a Dehydrogenases 
653 |a Oxidative stress 
653 |a Proteins 
653 |a Nitric-oxide synthase 
653 |a Renal function 
653 |a Reactive nitrogen species 
653 |a Gene expression 
653 |a Klotho protein 
653 |a Cardiomyocytes 
653 |a Ostomy 
653 |a Lipid metabolism 
653 |a Muscle contraction 
653 |a Matrix metalloproteinase 
653 |a Homeostasis 
653 |a Kidneys 
653 |a Gelatinase A 
653 |a Gelatinase B 
653 |a Protein turnover 
653 |a Signal transduction 
653 |a Mechanical properties 
653 |a Social 
653 |a Environmental 
700 1 |a Krzywonos-Zawadzka, Anna  |u Division of Clinical Chemistry and Laboratory Haematology, Department of Medical Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A St., 50-556, Wrocław, Poland (ROR: https://ror.org/01qpw1b93) (GRID: grid.4495.c) (ISNI: 0000 0001 1090 049X) 
700 1 |a Sambor, Izabela  |u Department of Biochemistry and Molecular Biology, Wroclaw University of Environmental and Life Sciences, Wrocław, Poland (ROR: https://ror.org/05cs8k179) (GRID: grid.411200.6) (ISNI: 0000 0001 0694 6014) 
700 1 |a Mysiak, Andrzej  |u Institute of Heart Diseases, Wroclaw Medical University, Wrocław, Poland (ROR: https://ror.org/01qpw1b93) (GRID: grid.4495.c) (ISNI: 0000 0001 1090 049X) 
700 1 |a Bil-Lula, Iwona  |u Division of Clinical Chemistry and Laboratory Haematology, Department of Medical Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A St., 50-556, Wrocław, Poland (ROR: https://ror.org/01qpw1b93) (GRID: grid.4495.c) (ISNI: 0000 0001 1090 049X) 
773 0 |t Scientific Reports (Nature Publisher Group)  |g vol. 15, no. 1 (2025), p. 32299-32316 
786 0 |d ProQuest  |t Science Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3245813375/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3245813375/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3245813375/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch